Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-κB Pathway in Mice
Sepsis is one of the most severe complications and causes of mortality in the clinic. It remains a great challenge with no effective treatment for clinicians worldwide. Inhibiting the release of proinflammatory cytokines during sepsis is considered as an important strategy for treating sepsis and im...
Saved in:
Main Authors: | He Fang (Author), Xingtong Wang (Author), Mahendra Damarla (Author), Rongju Sun (Author), Qingli He (Author), Ruojing Li (Author), Pengfei Luo (Author), Jun O. Liu (Author), Zhaofan Xia (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced IκBζ expression in macrophages
by: Yong Zhang, et al.
Published: (2023) -
Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023) -
Dimethyl fumarate for treating Papillon-Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023) -
Toddalolactone Protects Lipopolysaccharide-Induced Sepsis and Attenuates Lipopolysaccharide-Induced Inflammatory Response by Modulating HMGB1-NF-κB Translocation
by: Jingyu Ni, et al.
Published: (2020) -
Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021)